The Claim

In patients with severe COVID-19 pneumonia, administration of high-dose intravenous vitamin C (6 g/day for 96 hours) was associated with a smaller increase in C-reactive protein levels and a smaller rise in procalcitonin levels compared to controls.

Source: The effect of High-Dose Vitamin C Treatment for Acute Respiratory Failure Due to Coronavirus Disease Pneumonia on Mortality and Length of Intensive Care Stay: A Retrospective Cohort Study

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
53score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Correlation
1 study reviewed
In plain English

In patients with severe COVID-19 pneumonia, intravenous vitamin C at 6 grams per day for four days was associated with lower increases in two markers of inflammation—C-reactive protein and procalcitonin—compared to patients who did not receive it.

See the scientific wording

In patients with severe COVID-19 pneumonia, high-dose intravenous vitamin C (6 g/day for 96 hours) was associated with a smaller increase in C-reactive protein (CRP) levels (median change -41 mg/dL vs. +19 mg/dL) and a smaller rise in procalcitonin (median increase +0.1 ng/mL vs. +0.9 ng/mL) compared to controls, indicating a potential dampening effect on systemic inflammation.

Why this might work

High doses of vitamin C enter the bloodstream and reach inflamed tissues, where it neutralizes harmful molecules produced during infection. This reduces the activation of a key cellular switch that turns on inflammation genes, leading to less production of inflammatory signals. As a result, the body releases fewer markers of inflammation like CRP and procalcitonin.

Supported mechanismbased on 1 study

What the research says

1 study

  1. Study: The effect of High-Dose Vitamin C Treatment for Acute Respiratory Failure Due to Coronavirus Disease Pneumonia on Mortality and Length of Intensive Care Stay: A Retrospective Cohort Study

    In very sick COVID patients, high-dose vitamin C didn’t save more lives or shorten hospital stays, but it did help lower two key signs of body inflammation—CRP and procalcitonin—compared to patients who didn’t get it. So yes, it seems to calm inflammation.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.